Literature DB >> 1579447

Mammalian p53 can function as a transcription factor in yeast.

E Schärer1, R Iggo.   

Abstract

p53 has previously been shown to contain a transactivation domain using GAL4 fusion proteins and to bind specifically to a 33 base pair DNA sequence in immunoprecipitation assays. We show here that mammalian p53 expressed in S. cerevisiae is able to activate transcription of a reporter gene placed under the control of a CYC1 hybrid promoter containing the 33 base pair p53-binding sequence. The activation is dependent on the orientation and number of copies of the binding site. Three p53 mutants commonly found in human tumours, 175H, 248W and 273H, are unable to activate transcription. A fourth human p53 mutant, 285K, is temperature-sensitive for transcriptional activation. Murine p53 activates transcription from the same sequence. The murine 135V mutant, which is temperature-sensitive for mammalian cell transformation, is also temperature-sensitive for transcriptional activation. There is a much better correlation between mutation and transcriptional competence than between mutation and the structure of p53 determined with conformation-sensitive antibodies. We have therefore developed a simple transcription assay for p53 mutation in which yeast are transfected with p53 PCR products and mutation is scored on X-gal plates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1579447      PMCID: PMC312235          DOI: 10.1093/nar/20.7.1539

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  70 in total

1.  Monoclonal antibody analysis of p53 expression in normal and transformed cells.

Authors:  J W Yewdell; J V Gannon; D P Lane
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

Review 2.  p53: oncogene or anti-oncogene?

Authors:  D P Lane; S Benchimol
Journal:  Genes Dev       Date:  1990-01       Impact factor: 11.361

3.  Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents.

Authors:  A J Fornace; D W Nebert; M C Hollander; J D Luethy; M Papathanasiou; J Fargnoli; N J Holbrook
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

4.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

5.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells.

Authors:  P Sarnow; Y S Ho; J Williams; A J Levine
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

6.  The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter.

Authors:  W S Dynan; R Tjian
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

7.  Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

Authors:  D Wolf; N Harris; V Rotter
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

8.  SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000.

Authors:  D P Lane; W K Hoeffler
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

9.  Heme regulates transcription of the CYC1 gene of S. cerevisiae via an upstream activation site.

Authors:  L Guarente; T Mason
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

10.  Monoclonal antibodies against simian virus 40 nuclear large T tumour antigen: epitope mapping, papova virus cross-reaction and cell surface staining.

Authors:  R K Ball; B Siegl; S Quellhorst; G Brandner; D G Braun
Journal:  EMBO J       Date:  1984-07       Impact factor: 11.598

View more
  67 in total

1.  In vitro evolution of thermostable p53 variants.

Authors:  I Matsumura; A D Ellington
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53.

Authors:  D M Milne; R H Palmer; D W Meek
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

3.  Evidence of a Prion-Like Transmission of p53 Amyloid in Saccharomyces cerevisiae.

Authors:  Shinjinee Sengupta; Samir K Maji; Santanu K Ghosh
Journal:  Mol Cell Biol       Date:  2017-08-28       Impact factor: 4.272

4.  Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins.

Authors:  J D Benson; R Lawande; P M Howley
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.

Authors:  S K Thukral; G C Blain; K K Chang; S Fields
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  PAK1, a gene that can regulate p53 activity in yeast.

Authors:  S Thiagalingam; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 7.  The first 30 years of p53: growing ever more complex.

Authors:  Arnold J Levine; Moshe Oren
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

Review 8.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

9.  Single plasmids expressing human steroid hormone receptors and a reporter gene for use in yeast signaling assays.

Authors:  Charles A Miller; Xiaobing Tan; Mark Wilson; Sunanda Bhattacharyya; Sara Ludwig
Journal:  Plasmid       Date:  2009-12-03       Impact factor: 3.466

10.  High frequency of temperature-sensitive mutants of p53 in glioblastoma.

Authors:  Jana Smardova; Kvetoslava Liskova; Barbora Ravcukova; Lenka Kubiczkova; Sabina Sevcikova; Jaroslav Michalek; Miluse Svitakova; Vaclav Vybihal; Leos Kren; Jan Smarda
Journal:  Pathol Oncol Res       Date:  2013-03-28       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.